Russia's cancer vaccine, comprising EnteroMix and personalized mRNA vaccines, has completed preclinical trials, showcasing safety and high ...

Russia's Federal Medical Biological Agency (FMBA) has announced the successful completion of preclinical trials for its cancer vaccine, dem...

According to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...

In a written response to a question in the Rajya Sabha, Union Science and Technology Minister Jitendra Singh said Cadila Healthcare Ltd's D...

Covaxin, a whole-virion inactivated coronavirus vaccine, is the first and only product to have published any data from human clinical trial...

Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmace...

“Nationally, nearly 30 Covid-19 vaccine candidates are under development, by both industry and academia. These vaccines are in different st...

Union Minister of State for Home Nityanand Rai also told the Rajya Sabha that 13 clinical trials of repurposed drugs have been undertaken t...

Serum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates.

The company has developed the vaccine in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Vir...

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma...

Zydus Cadila's move to begin human trials of its indigenously developed vaccine candidate for COVID-19 is an important milestone for an 'At...

The company said in the preclinical stage the vaccine was found to be safe, immunogenic and well-tolerated. It was also able to produce neu...

The SARS-CoV-2 strain was isolated in NIV and transferred to Bharat Biotech, which has developed the indigenous, inactivated vaccine at its...

SII announced that a vaccine candidate for the novel coronavirus, which has killed more than 2,000 people in China since its outbreak in De...

In a statement, the company said “the placebo controlled study involving 60 healthy volunteers would test escalating doses of the vaccine i...

The department of biotechnology (DBT) is planning to set up the National Biotechnology Regulatory Board to specify and regulate development...